Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06061861 · ClinicalTrials.gov registry record · NA
Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study
A NA study of Diabetes Mellitus, Type 2, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 1,007
- Enrollment target
- 2
- Study locations
NCT06061861: Active NA study of Diabetes Mellitus, Type 2, sponsored by Kaiser Permanente.
NCT06061861 is a NA study of Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,007 participants, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06061861, a NA study of Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,007 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (HbA1c) levels among adults with type 2 diabetes mellitus with glycemic control that is above target level. The main study aims are to: 1. To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces glycosylated hemoglobin levels within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control. 2. To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces medical resource utilization within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control.
Primary Outcome
Baseline glycosylated hemoglobin will be ascertained using routine laboratory tests in the electronic health record prior to enrollment. Participants will complete glycosylated hemoglobin testing 6 months after enrollment.
Conditions Studied
Interventions
- OTHER Financial support for healthy foods and free home delivery
- OTHER Free home delivery
Study Locations (2)
California
- Kaiser Permanente Southern California Department of Research & Evaluation - Pasadena
- Kaiser Permanente Northern California Division of Research - Pleasanton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,007 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT06061861 still lists
NCT06061861 is an interventional study that assigns participants to a tested intervention. Its 1,007 participants enrollment target places it among the larger protocols in the corpus, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Financial support for healthy foods and free home delivery is the first listed.
NCT06061861 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06061861 about?
NCT06061861 is a clinical study titled "Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study". The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (HbA1c) levels among adults with type 2 diabetes mellitus with glycemic control that is above target ...
What is the current status of trial NCT06061861?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,007 participants. The study started on 2023-10-01. Estimated completion is 2026-06.
What conditions does trial NCT06061861 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT06061861?
The interventions under investigation include: Financial support for healthy foods and free home delivery (OTHER), Free home delivery (OTHER).
Who is sponsoring clinical trial NCT06061861?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06061861 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06061861's enrollment target sits among peer trials
1,007 35th of 348 higher than 314 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI